Literature DB >> 6256579

[The effects of topical steroids in epidemic kerato-conjunctivitis (author's transl)].

S Trauzettel-Klosinski, R Sundmacher, R Wigand.   

Abstract

Fifty-three patients with proven adenovirus type 8 infection were treated at random, in a prospective study, with either artificial tears or topical steroids over six weeks. Severe cases of nummular keratitis, as well as deep keratitis and slight iritis, were significantly less frequent under steroids. No difference existed with respect to the course of the conjunctivitis and the frequency of a superficial punctate keratitis. Furthermore, the overall frequency of nummular keratitis was equal in both groups, its manifestation merely being somewhat delayed in the steroid group. This may even be disadvantageous, as the natural course of the disease could be prolonged. A significant disadvantage of topical steroids, however, was the high incidence of permanent "dry eye" in the post-infection period. Therefore, as long as no effective antiviral treatment for adenovirus infection is available, steroids should only be administered to relieve symptoms in severe cases for a limited time.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6256579     DOI: 10.1055/s-2008-1057579

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  8 in total

1.  Topical human fibroblast interferon for acute adenoviral conjunctivitis.

Authors:  K R Wilhelmus; E C Dunkel; J Herson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

Review 2.  Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Authors:  Birthe Meyer-Rüsenberg; Ulrike Loderstädt; Gisbert Richard; Paul-Michael Kaulfers; Caroline Gesser
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

3.  Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.

Authors:  L Asena; E Şıngar Özdemir; A Burcu; E Ercan; M Çolak; D D Altınörs
Journal:  Eye (Lond)       Date:  2017-02-03       Impact factor: 3.775

4.  The value of exogenous interferon in adenovirus keratoconjunctivitis. Preliminary results.

Authors:  R Sundmacher; R Wigand; K Cantell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

5.  [Adenoviral keratoconjunctivitis].

Authors:  U Pleyer; F Birnbaum
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

Review 6.  Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.

Authors:  Su-Hsun Liu; Barbara S Hawkins; Sueko M Ng; Mark Ren; Louis Leslie; Genie Han; Irene C Kuo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-03

Review 7.  Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.

Authors:  Rahul A Jonas; Lawson Ung; Jaya Rajaiya; James Chodosh
Journal:  Prog Retin Eye Res       Date:  2019-12-28       Impact factor: 21.198

8.  Role of Anterior Segment Optical Coherence Tomography in Monitoring Epidemic Keratoconjunctivitis.

Authors:  Dhouha Gouider; Asma Khallouli; Afef Maalej; Sana Khochtali; Moncef Khairallah
Journal:  J Curr Ophthalmol       Date:  2022-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.